The FDA has warned of a serious potential issue with Novum IQ large-volume infusion pumps made by Baxter . Our sister site, Drug Delivery Business News, reports today that Baxter recently warned customers of the potential for underinfusion with the pump. According to the FDA’s notice, keeping the administration set loaded in the pump for an […]
Baxter
Former Baxter kidney unit Vantive to invest $1B in digitally enabled therapies
Vantive, the former kidney care unit of Baxter, today announced plans to invest more than $1 billion in new technology over the next five years. The business, which Baxter sold to a private equity firm for nearly $4 billion, plans to use the investment to expand R&D and production capacity. It hopes to fuel innovation […]
Baxter launches room-temperature collagen sealing pad
Baxter announced today that it launched its latest Hemopatch sealing hemostat pad. The room-temperature collagen pad, approved for hemostasis and sealing, features an extended shelf life of three years. It involves the interaction of two components that can create rapid and lasting hemostasis by sealing off the bleeding surface. Preclinical studies have shown that patch […]
BD files patent infringement lawsuit against Baxter over infusion pump tech
BD (NYSE:BDX) has alleged patent infringement by Baxter (NYSE:BAX) in a new legal complaint related to infusion pump technology. Our sister site, Drug Delivery Business News, reports today that BD filed its complaint in the U.S. District Court for the District of Delaware on May 12, 2025, alleging the “infringing manufacture, use, importation, offer for sale, […]
Baxter beats the Street in Q1, increases full-year guidance
Baxter today reported first quarter results that exceeded expectations. The Deerfield, Illinois–based medtech company reported sales of $2.63 billion for the first quarter (ended March 31), up 5% from the same quarter a year ago. Adjusted earnings per share (EPS) came in at $0.55. Those results beat Wall Street analysts’ expectations for adjusted EPS of […]
Medtech stocks sink in trade war
The past week has been tough on the stocks of major medtech companies, which, like many, are figuring out how to manage the Trump administration’s new global trade war. The S&P 500 briefly entered bear market territory today as it swung wildly in response to chaotic news reports about what the administration and other countries […]
Baxter stock rises on Street-beating, better-than-expected Q4
Baxter shares rose today on fourth-quarter results that came in ahead of the consensus forecast. Shares of BAX ticked up 8% to $33.29 apiece in midday trading today. The Deerfield, Illinois–based medtech company reported losses of $512 million. That equals $1 per share on results from both continuing operations and discontinued operations. Baxter recorded sales […]
Baxter CEO Almeida to retire, Kidney Care business becomes standalone company
Baxter announced today that José (Joe) E. Almeida, its chair, president and CEO, plans to retire, effective immediately. The company also announced the appointment of a new chief operating officer and that its former Kidney Care business now stands alone as “Vantive.” Almeida retired from all his executive roles but plans to serve in an […]
The biggest medtech M&A moves of 2024
In 2024, we saw another proactive year for some of the biggest names in medtech as they looked to bolster their ranks through acquisitions. Over the course of the year, the number of billion-dollar sales deals continued to climb, with some companies involved more than once. Analysts even suggested that, in 2025, there could be […]
Layoffs in medtech: These companies recently reduced their workforce
Medtech layoffs are picking up as 2024 draws to a close. Sean Whooley, Associate Editor, and Chris Newmarker, Editor-in-Chief The medical device industry is closing out the year with a fresh round of layoffs. At this point, MassDevice has reported on more than 22,000 medtech job cuts across the industry since mid-2022. (Have a tip […]
Baxter expects $200M hit from hurricane, decreases full-year forecast
Baxter (NYSE: BAX) today said it expects to lose out on at least $200 million worth of sales due to flooding at its North Cove manufacturing facility from Hurricane Helene. That estimate — which includes about $40 million to $50 million worth of Kidney Care sales and around $150 million to $160 million worth of […]
